Early & Late Stage Asset evaluation Planning and Development

What We Do

We provide strategic consulting to pharmaceuticals companies, biotech and VC firms on multiple touchpoints during asset planning and drug development journey.

Ophthalmology

Front and back of the eye disease indications

Cell & Gene Therapy

AAV/CRISPR based cell and gene therapy indications

Neuroscience

Broad array of neurological diseases and disorders 

Rare/Orphan Diseases

Genetic and orphan diseases across multiple TAs

About Us

Our capabilities and know-how include early and late stage asset planning & development, asset validation & due diligence, business development, corporate and commercial strategy support on varoius therepeutic areas of focus.

“We help accelerate your pipeline assets” 

IconA1
+ YR EXPERIENCE
0
+ THERAPEUTIC AREAS
0
+ DISEASE FOCUS AREAS
0
% SCIENCE-DRIVEN
0
We bring 360° in-depth scientific experience and expertise in preclinical and clinical drug development in ophthalmology an other disease focus areas.
Ophthalmology
Anterior and posterior segment diseases
Neuroscience
Neurodegenrative diseases and disorders
Gene Therapy
Inherited retinal diseases and indications
Orphan Diseases
Rare diseases and disorders in multiple TAs

Where We Help

We provide strategic and technical consulting covering drug development aspect from R&D discovery, preclinical & clinical planning and development, market and asset data analytics, corporate strategy, BD and M&A support on multiple therapeutics and disease focus areas.
Preclinical & Clinical Development
We provide preclinical and clinical development support on drug candidates & target assets.
Corporate & Commercial Support
We provide corporate, BD and commercial strategy support on internal & external assets of interest.

Contact Us

Office

4445 Eastgate Mall, Ste 200, San Diego, CA 92121

Phone

(+1) 858-461-8307